Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Diabetes mellitus
ADR ID BADD_A01238
ADR Hierarchy
05      Endocrine disorders
05.06      Glucose metabolism disorders (incl diabetes mellitus)
05.06.01      Diabetes mellitus (incl subtypes)
05.06.01.001      Diabetes mellitus
14      Metabolism and nutrition disorders
14.06      Glucose metabolism disorders (incl diabetes mellitus)
14.06.01      Diabetes mellitus (incl subtypes)
14.06.01.001      Diabetes mellitus
Description A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. [MeSH]
MedDRA Code 10012601
MeSH ID D003920
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Diabetes | Diabetes mellitus | Diabetes mellitus aggravated | Diabetes mellitus exacerbated | Diabetes mellitus NOS | Diabetes mellitus precipitated | Diabetes mellitus reactivated | Diabetes mellitus without mention of complication | Diabetes reactivated | Diabetic | Worsening of diabetes | Post transplant diabetes mellitus | Diabetes mellitus progression | Diabetes Mellitus
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02317Unoprostone isopropyl--
BADD_D02325Valdecoxib--
BADD_D02326Valganciclovir--
BADD_D02329Valproic acid--
BADD_D02331Valsartan0.001439%
BADD_D02337Varenicline0.001363%
BADD_D02338Varenicline tartrate--
BADD_D02346Venlafaxine0.000080%
BADD_D02369Voriconazole0.020330%
BADD_D02375Water--
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02383Zidovudine0.006631%
BADD_D02389Ziprasidone hydrochloride--
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide0.001025%
BADD_D02432Glycopyrronium0.001891%
BADD_D02436Atorvastatin0.000175%
BADD_D02445Solifenacin0.000174%
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.004750%
BADD_D02470Nintedanib--
BADD_D02473Sodium chloride--
BADD_D02480Alectinib0.000224%
BADD_D02483Ribociclib0.000470%
BADD_D02485Talazoparib0.000112%
BADD_D02487Baricitinib0.000241%
BADD_D02500Alpelisib0.001903%
BADD_D02504Lorlatinib0.000448%
BADD_D02509Brigatinib0.000280%
The 12th Page    First    Pre   12 13    Next   Last    Total 13 Pages
ADReCS-Target
ADR Term Drug Name Target